Rare diseases
Investigational molecules
Locations
Back to Bulgaria437 clinical trials in Plovdiv, Bulgaria across 5 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study of TP-3654 and Momelotinib for Patients with Intermediate or High-risk Myelofibrosis
BulgariaStudy of Sarilumab for Children and Adolescents with Systemic Juvenile Idiopathic Arthritis (sJIA)
BulgariaStudy for Patients with BRCA Mutated Ovarian, Breast, Pancreatic, Prostate, and Endometrial Cancers Continuing Olaparib Treatment
BulgariaStudy on the Effects of IMU-838 (Vidofludimus Calcium) for Patients with Relapsing-Remitting Multiple Sclerosis
BulgariaStudy on the Effects of Vidofludimus Calcium (IMU-838) in Patients with Progressive Multiple Sclerosis
BulgariaStudy on Long-Term Safety of Cenerimod for Adults with Moderate-to-Severe Systemic Lupus Erythematosus
BulgariaStudy on the Effectiveness and Safety of Saruparib and Camizestrant in Adults with Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
BulgariaStudy on Efepoetin Alfa and Darbepoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis
BulgariaStudy of Adagrasib Alone and with Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation
BulgariaTitle: Long-term treatment study of oral decitabine and cedazuridine combination for patients with AML, MDS, CMML, or solid tumors who previously received ASTX727
BulgariaStudy on VE303 for Preventing Recurrent C. difficile Infection in Patients
BulgariaStudy on the Safety and Benefits of Recombinant Human Plasma Gelsolin for Patients with Moderate-to-Severe Acute Respiratory Distress Syndrome (ARDS)
BulgariaThe busiest research cities in the country
What the registry says about research in the country
Ongoing research focuses on influenza virus prevention and hepatitis delta infection treatment. Clinical trials are evaluating new vaccine formulations and therapeutic approaches for viral infections.
Studies include testing of adjuvanted vaccines and novel antiviral medications for chronic conditions.
Research initiatives targeting hypertriglyceridemia and heart failure prevention. Studies are exploring innovative treatments for metabolic conditions and cardiovascular risk reduction.
Trials evaluate new compounds for managing metabolic disorders and preventing cardiovascular events.
Comprehensive studies on psoriatic arthritis, Sjögren's disease, and systemic sclerosis. Research focuses on innovative biological therapies and treatment approaches.
Clinical trials are investigating novel therapeutic agents for managing chronic autoimmune conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
